| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |